Jupiter Neurosciences Signs ALA-002 License Agreement Worth Up to $100 Million

Jupiter Neurosciences has signed a license agreement for ALA-002, potentially valued at up to $100 million. This deal represents a significant development for the company's pharmaceutical pipeline and financial outlook.